Showing results (41-50 of 70) with videos related to
Sort By:
Pageof 7
Medical Oncology (Northwood, London, England)|May 25, 2006
The value of serum bcl-2 levels in advanced epithelial ovarian cancerFaruk Tas, Derya Duranyildiz, Hilal Oguz, et al.Cancer Investigation|August 31, 2006
Serum vascular endothelial growth factor (VEGF) and interleukin-8 (IL-8) levels in small cell lung cancerFaruk Tas, Derya Duranyildiz, Hilal Oguz, et al.Cancer Investigation|September 20, 2006
Serum vascular endothelial growth factor (VEGF) and bcl-2 levels in advanced stage non-small cell lung cancerFaruk Tas, Derya Duranyildiz, Hilal Oguz, et al.Journal of Gastrointestinal Cancer|June 15, 2013
Clinical significance of coagulation assays in metastatic pancreatic adenocarcinomaFaruk Tas, Senem Karabulut, Elif Bilgin, et al.Wiener Klinische Wochenschrift|August 24, 2019
Serum nectin-2 and nectin-4 are diagnostic in lung cancer: which is superior?Kayhan Erturk, Sule Karaman, Nergiz Dagoglu, et al.Cancer Investigation|December 7, 2007
Macrophage migration inhibitory factor in cancerVildan Yasasever, Hakan Camlica, Derya Duranyildiz, et al.Medical Oncology (Northwood, London, England)|January 22, 2008
Effect of zoledronic acid on serum angiogenic factors in patients with bone metastasesFaruk Tas, Derya Duranyildiz, Hilal Oguz, et al.Medical Oncology (Northwood, London, England)|November 2, 2005
Serum levels of leptin and proinflammatory cytokines in advanced-stage non-small cell lung cancerFaruk Tas, Derya Duranyildiz, Andac Argon, et al.American Journal of Clinical Oncology|June 1, 2004
Clinical value of protein S100 and melanoma-inhibitory activity (MIA) in malignant melanomaFaruk Tas, Vildan Yasasever, Derya Duranyildiz, et al.Medical Oncology (Northwood, London, England)|August 20, 2005
The value of serum levels of IL-6, TNF-alpha, and erythropoietin in metastatic malignant melanoma: serum IL-6 level is a valuable prognostic factor at least as serum LDH in advanced melanomaFaruk Tas, Hilal Oguz, Andaç Argon, et al.Pageof 7